BioMarin Pharmaceutical Inc. Falling On The Genzyme News

Symbols: BMRN
Posted in: Movers
Share

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) is falling some 4% on news that some Genzyme drugs could be contaminated.

BioMarin Pharma has three approved products and multiple investigational product candidates.


 
 
< Previous
Genzyme Dropping Because of FDA Warning (GENZ)
Next >
Abercrombie & Fitch (ANF) results surpasses analysts' expectations
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust

Special Offers:
Quick Cash Advance